133 related articles for article (PubMed ID: 31360355)
1. Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015.
Nabavi M; Hatami H; Jamaliarand H
Int J Prev Med; 2019; 10():108. PubMed ID: 31360355
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran.
Kassiri H; Amani H; Lotfi M
Asian Pac J Trop Biomed; 2013 Aug; 3(8):589-94; discussion 593-4. PubMed ID: 23905014
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic, clinical, and laboratory characteristics of childhood brucellosis : A study in an Iranian children's referral hospital.
Pourakbari B; Abdolsalehi M; Mahmoudi S; Banar M; Masoumpour F; Mamishi S
Wien Med Wochenschr; 2019 Jun; 169(9-10):232-239. PubMed ID: 30778882
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.
Mohammadbeigi A; Saghafipour A; Hamta A; Khazaei S; Maghsoudi A; Shams S
Ghana Med J; 2021 Sep; 55(3):206-212. PubMed ID: 35950176
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of Brucellosis in Kermanshah Province, Iran During 2010-2014.
Rajabi J; Hamidi-Farahani R; Mansouri F; Soleiman-Meigooni S
Infect Disord Drug Targets; 2020; 20(2):203-207. PubMed ID: 30539704
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological features of human brucellosis in central Iran, 2006-2011.
Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Brucellosis among General Population in Famenin City, Western Iran in 2016: The Famenin Brucellosis Cohort Study.
Keramat F; Karami M; Alikhani MY; Bashirian S; Moghimbeigi A; Hashemi SH; Mamani M; Shivapoor Z; Bosilkovski M; Adabi M
Arch Iran Med; 2020 Nov; 23(11):749-756. PubMed ID: 33220691
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Epidemiology of Brucellosis Cases in Iran during the Last Decade.
Zeinali M; Doosti S; Amiri B; Gouya MM; Godwin GN
Iran J Public Health; 2022 Dec; 51(12):2791-2798. PubMed ID: 36742247
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature.
Buzgan T; Karahocagil MK; Irmak H; Baran AI; Karsen H; Evirgen O; Akdeniz H
Int J Infect Dis; 2010 Jun; 14(6):e469-78. PubMed ID: 19910232
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.
Eini P; Keramat F; Hasanzadehhoseinabadi M
J Res Health Sci; 2012 Dec; 12(2):105-8. PubMed ID: 23241521
[TBL] [Abstract][Full Text] [Related]
11. Trends of human brucellosis in Central Iran (2010-2018).
Khalilian MS; Ramazanpour J; Hosseini SM; Narrei S; Zeinalian M
J Res Med Sci; 2021; 26():55. PubMed ID: 34729063
[TBL] [Abstract][Full Text] [Related]
12. Spatial Distribution and Epidemiological Factors of Brucellosis in Ardabil Province, Iran.
Jafarzadeh M; Habibzadeh S; Moradi-Asl E; Mohamadshahi J; Abishvand J; Nakhostin B
Health Serv Res Manag Epidemiol; 2023; 10():23333928231211412. PubMed ID: 37954480
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations, laboratory findings, and therapeutic regimen in hospitalized children with brucellosis in an Iranian Referral Children Medical Centre.
Fanni F; Shahbaznejad L; Pourakbari B; Mahmoudi S; Mamishi S
J Health Popul Nutr; 2013 Jun; 31(2):218-22. PubMed ID: 23930340
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of human brucellosis in Nahavand county, Hamadan Province, western Iran: an 8-year (2010-2017) registry-based analysis.
Khazaei S; Solgi M; Goodarzi S; Khazaei L; Salehi I; Jenabi E
Asian Biomed (Res Rev News); 2020 Aug; 14(4):151-158. PubMed ID: 37551387
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Relapse of Human Brucellosis.
Hasanjani Roushan MR; Moulana Z; Mohseni Afshar Z; Ebrahimpour S
Glob J Health Sci; 2015 Nov; 8(7):77-82. PubMed ID: 26925907
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of brucellosis disease using data mining: A case study on patients of a hospital in Tehran.
Sebt MV; Jafari S; Khavaninzadeh M; Shavandi A
J Microbiol Methods; 2022 Aug; 199():106530. PubMed ID: 35777597
[TBL] [Abstract][Full Text] [Related]
17. Skeletal complications of brucellosis: A study of 464 cases in Babol, Iran.
Ebrahimpour S; Bayani M; Moulana Z; Hasanjani Roushan MR
Caspian J Intern Med; 2017; 8(1):44-48. PubMed ID: 28503282
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological Characteristics and Trend in the Incidence of Human Brucellosis in Iran from 2009 to 2017.
Norouzinezhad F; Erfani H; Norouzinejad A; Ghaffari F; Kaveh F
J Res Health Sci; 2021 Dec; 21(4):e00535. PubMed ID: 36511231
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical features of Brucella arthritis in 24 children.
Zamani A; Kooraki S; Mohazab RA; Zamani N; Matloob R; Hayatbakhsh MR; Raeeskarami SR
Ann Saudi Med; 2011; 31(3):270-3. PubMed ID: 21623056
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of human brucellosis in Isfahan, Iran.
Sabbaghian H; Nadim A
J Hyg (Lond); 1974 Oct; 73(2):221-8. PubMed ID: 4529097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
